Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Keytruda "not very good and costly..."

<< Previous

Bullboard Posts

Next >>

Comment by wildbird1on Apr 13, 2023 11:11am

141 Views

Post# 35393008

RE:Keytruda "not very good and costly..."

DJDawg, you are absolutely right...

1) It does confirm that when Dr.Argawal talk about the coming of better and less costly therapies, he is definitively talking about TLT treatment.

2) Dr.Argawal has also served on the FDA oncology drug advisory committee(ODAC), his experience on the ODAC, give him more credibility when he said that new therapies(like TLT) are coming soon.

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!